In another encouraging vaccine development from the Old Continent, European Commission President Ursula von der Leyen announced on Saturday that the EU has struck a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of their Covid-19 vaccine.
“Happy to announce that the EU Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with BioNTech/Pfizer for 2021-2023,” European Commission Chief tweeted from an EU summit in Portugal.
von der Leyen has said previously said, “the mRNA technology used by BioNTech/Pfizer and other vaccine-makers has proven safe and effective.”
After a low start to the vaccination campaign, the 27-nation bloc is on track to have 70% of the adult population fully vaccinated by end July.
Share
